(Senior) Benefit Risk Scientist jobs in United States
cer-icon
Apply on Employer Site
company-logo

UCB · 4 weeks ago

(Senior) Benefit Risk Scientist

positionRaleigh, North Carolina, US
timeFull-time
remoteHybrid
seniorityMid, Senior Level
money$124K/yr - $163K/yr

UCB is a global biopharmaceutical company focusing on neurology and immunology. They are seeking a Senior Benefit Risk Scientist to evaluate, interpret, and communicate benefit-risk insights across various medicines, while supporting safety and benefit-risk strategies in clinical development.

BiotechnologyHealth CarePharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Analyse and interpret data from multiple sources to identify and assess potential new risks and incorporate findings into benefit–risk plans
Support the implementation of safety monitoring and risk management strategies in clinical development programs
Prepare and contribute to high‑quality benefit–risk and safety documentation for regulatory submissions
Ensure scientific accuracy, clarity, and compliance in all written deliverables
Collaborate with stakeholders to ensure timely escalation and alignment on safety topics
Stay current on scientific and regulatory developments relevant to benefit–risk assessment

Qualification

Benefit-risk assessmentSafety evaluationData analysisBiopharmaceutical experienceRegulatory complianceOrganizational skillsCommunication skillsAdaptability

Required

Advanced degree in a scientific field (required)
Experience in the biopharmaceutical industry with exposure to safety evaluation or benefit–risk assessment
Demonstrable experience in supporting multiple safety-related outputs and working knowledge of the international regulations governing drug safety
Ability to analyse complex data and communicate findings clearly
Strong organisational skills with the ability to work on multiple projects
Excellent written and verbal communication skills in English
Ability to adapt in dynamic environments and apply sound judgement

Company

UCB

twittertwittertwitter
Glassdoor3.9
company-logo
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.
dateFounded in 1928
location
Brussels, Brussels Hoofdstedelijk Gewest, BEL
people-size5001-10000 employees
web-link
http://www.ucb.com

H1B Sponsorship

UCB has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (7)
2023 (3)
2022 (4)
2021 (4)
2020 (1)

Funding

Current Stage
Public Company
Total Funding
$201.75M
Key Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M

Leadership Team

leader-logo
Jean-Christophe Tellier
CEO
linkedin
leader-logo
Stefanos Grammatikos
Senior Vice President - Head of CMC Development Sciences
linkedin

Recent News

Canada NewsWire
PrBIMZELX® (bimekizumab injection) approved in Canada for treatment of moderate to severe hidradenitis suppurativa (HS) Français
2026-01-15
PharmiWeb
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
2025-12-10
PR Newswire
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
2025-12-08
Company data provided by crunchbase